Home > Boards > US OTC > Biotechs > Aerpio Pharmaceuticals, Inc. (ARPO) (ARPO)

1.40

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
ALERTS100%to10000%GAIN Member Profile
Member Level 
Followed By 952
Posts 74,679
Boards Moderated 37
Alias Born 03/10/09
160x600 placeholder
Quantum halts testing Aerpio Pharmaceuticals' razuprotafib in COVID-19 setting Seeking Alpha - 3/5/2021 8:09:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/16/2021 4:37:25 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/10/2021 3:23:26 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/10/2021 10:32:20 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/11/2021 6:02:01 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/5/2021 4:11:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/11/2020 5:09:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/10/2020 5:05:32 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 11/23/2020 6:01:08 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 11/12/2020 5:16:41 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/10/2020 8:33:14 AM
Aravive Appoints Michael W. Rogers to Board of Directors GlobeNewswire Inc. - 9/17/2020 7:00:10 AM
Aerpio and Quantum Leap Announce First Patients Dosed with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-... PR Newswire (US) - 9/1/2020 4:30:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/12/2020 8:49:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/12/2020 8:12:31 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/5/2020 7:30:57 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/26/2020 4:45:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/26/2020 4:44:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/26/2020 4:43:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/26/2020 4:41:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2020 8:56:47 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/8/2020 5:06:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/28/2020 9:13:40 AM
Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation ... PR Newswire (US) - 5/27/2020 4:30:00 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 5/15/2020 6:25:52 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2021 InvestorsHub.com, Inc.
Consent Preferences